5α-reductase inhibitors in men aged 50 years or older with androgenetic alopecia: a retrospective study

Androgenetic alopecia global photographs pre- and post-treatment of with 5α-reductase inhibitors (5ARI). The images compared patients before and after 5ARI treatment. Patient 1(M/55): greatly increased improvement(seven-point score: 3) after 10 months of dutasteride treatment (0.5 mg/d); patient 2(M/61): moderately increased improvement(seven-point score: 2) after 1 year of finasteride treatment (1 mg/d); patient 3(M/65): slightly increased improvement(seven-point score: 1) after 6 months of dutasteride treatment (0.5 mg/d); patient 4(M/77): slightly increased improvement(seven-point score: 1) after 9 months of finasteride treatment (1 mg/d).

本数据集包含使用5α-还原酶抑制剂（5ARI）治疗前后安格隆性脱发患者的全局照片。图像对比了接受5ARI治疗后患者治疗前后的情况。患者1（男性，55岁）：在接受10个月的度他沙坦治疗（每日0.5毫克）后，改善程度显著提高（七点评分：3分）；患者2（男性，61岁）：在接受1年的非那雄胺治疗（每日1毫克）后，改善程度中度提高（七点评分：2分）；患者3（男性，65岁）：在接受6个月的度他沙坦治疗（每日0.5毫克）后，改善程度略有提高（七点评分：1分）；患者4（男性，77岁）：在接受9个月的非那雄胺治疗（每日1毫克）后，改善程度略有提高（七点评分：1分）。